Meta-analysis of factors affecting prevalence estimates of HIV-associated neurocognitive disorder in sub-Saharan Africa

dc.contributor.authorNweke, Martins C.
dc.contributor.authorOkemuo, Adaora J.
dc.contributor.authorUduonu, Ekezie M.
dc.contributor.authorUgwu, Princewill I.
dc.contributor.authorNwachukwu, Chioma
dc.contributor.authorMshunqane, Nombeko
dc.contributor.emailmartins.nweke@gmail.comen_US
dc.date.accessioned2022-10-21T12:30:13Z
dc.date.available2022-10-21T12:30:13Z
dc.date.issued2021-09-29
dc.description.abstractSuccessful treatment of HIV with anti-retroviral therapy (ART) is resulting in more people living with HIV-associated neurocognitive disorder (HAND). In sub-Saharan Africa, this calls for strategic planning and judicious allocation of scarce resources, which requires an accurate estimate of the prevalence of HAND. Estimates of the prevalence of HAND in sub-Saharan Africa vary greatly, between 18.8% and 88.3%. This variability may be explained by factors such as different diagnostic approach, neuromedical examination, ART status, sampling method, substance abuse, assessors’ qualification, depression and outcome measure. Different methods of diagnosing HAND, different outcome measures and non-random sampling techniques make it almost impossible to accurately estimate the prevalence of HAND in subSaharan Africa, often resulting in overestimation of the burden of disease. Consumers of health research should consider certain study characteristics and exercise appropriate caution when interpreting burden of disease in sub-Saharan Africa, especially when pursuing policy shift. Underestimating the prevalence of HAND will certainly affect the capacity and speed of containment, while overestimating will draw unnecessary attention and result in the misallocation of scarce resources. Significance: • The high prevalence of HAND in sub-Saharan Africa as estimated in this review calls for further research on the impact of HAND on activities of daily living and putative therapeutic modalities. • We highlight which study characteristics should be critically checked when using prevalence estimates for the purpose of health policy and distribution of scarce resources in sub-Saharan Africa. • By favouring certain factors, this review will guide HIV health researchers in which techniques should be used to estimate the burden of HAND. These factors may also apply to estimating the burden of other diseases in sub-Saharan Africa.en_US
dc.description.departmentPhysiotherapyen_US
dc.description.sponsorshipUniversity of Pretoria.en_US
dc.description.urihttps://sajs.co.zaen_US
dc.identifier.citationNweke, M.C., Okemuo, A.J., Uduonu, E.M. et al. 2021, ‘Meta-analysis of factors affecting prevalence estimates of HIVassociated neurocognitive disorder in sub-Saharan Africa’, South African Journal of Science, vol. 117, no. 9/10, doi : 10.17159/sajs.2021/8575.en_US
dc.identifier.issn0038-2353 (print)
dc.identifier.issn1996-7489 (online)
dc.identifier.other10.17159/sajs.2021/8575
dc.identifier.urihttps://repository.up.ac.za/handle/2263/87884
dc.language.isoenen_US
dc.publisherAcademy of Science of South Africaen_US
dc.rights© 2021. The Author(s). Published under a Creative Commons Attribution Licence.en_US
dc.subjectHIV infectionen_US
dc.subjectNeurocognitive disorderen_US
dc.subjectPrevalenceen_US
dc.subjectStudy characteristicsen_US
dc.subjectHuman immunodeficiency virus (HIV)en_US
dc.subjectSub-Saharan Africa (SSA)en_US
dc.subjectAntiretroviral therapy (ART)en_US
dc.subjectHIV-associated neurocognitive disorder (HAND)en_US
dc.titleMeta-analysis of factors affecting prevalence estimates of HIV-associated neurocognitive disorder in sub-Saharan Africaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Nweke_MetaAnalysis_2021.pdf
Size:
816.04 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: